Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Sorensen · SciRah

Researcher profile · Semantic Scholar

S. Sorensen

Share profile

S. Sorensen — researcher profile on SciRah

h-index: 21
Works: 73
Citations: 1,329

Most-cited papers

Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: A Canadian payer perspective
S. Sorensen, A. Kansal, S. Connolly, S. Peng +3 more
2011Thrombosis and Haemostasis221 citations
Semantic Scholar
Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation
A. Kansal, S. Sorensen, R. Gani, P. Robinson +3 more
2012Heart125 citations Open access
Semantic Scholar
Cost-effectiveness of warfarin: trial versus "real-world" stroke prevention in atrial fibrillation.
S. Sorensen, S. Dewilde, D. Singer, S. Goldhaber +2 more
2009American Heart Journal81 citations
Semantic Scholar
Cost-effectiveness analysis of anastrozole versus tamoxifen as primary adjuvant therapy for postmenopausal women with early breast cancer: a US healthcare system perspective. The 5-year completed treatment analysis of the ATAC (‘Arimidex’, Tamoxifen Alone or in Combination) trial
G. Locker, R. Mansel, D. Cella, D. Dobrez +3 more
2007Breast Cancer Research and Treatment74 citations
Semantic Scholar
INCIDENCE-BASED COST-OF-ILLNESS MODEL FOR METASTATIC BREAST CANCER IN THE UNITED STATES
S. Sorensen, J. Goh, F. Pan, Connie Chen +6 more
2012International Journal of Technology Assessment in Health Care73 citations
Semantic Scholar
Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada
A. Kansal, Michael Sharma, C. Bradley-Kennedy, A. Clemens +4 more
2012Thrombosis and Haemostasis65 citations
Semantic Scholar
Systematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients
E. Bow, D. Vanness, M. Slavin, C. Cordonnier +11 more
2015BMC Infectious Diseases45 citations Open access
Semantic Scholar
Cost-Effectiveness of Linezolid vs Vancomycin in Suspected Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia in Germany
E. De Cock, W. Krueger, S. Sorensen, TM Baker +6 more
2009Infection45 citations
Semantic Scholar
Cost for inpatient care of venous thrombosis: a trial of enoxaparin vs standard heparin.
G. de Lissovoy, Roger D. Yusen, T. Spiro, William C. Krupski +2 more
2000Archives of Internal Medicine43 citations
Semantic Scholar
Comparison of the cost-effectiveness of new oral anticoagulants for the prevention of stroke and systemic embolism in atrial fibrillation in a UK setting.
Ying Zheng, S. Sorensen, A. Gonschior, H. Noack +3 more
2014Clinical Therapeutics41 citations Open access
Semantic Scholar
A comparison of costs and hospital length of stay associated with intravenous/oral linezolid or intravenous vancomycin treatment of complicated skin and soft-tissue infections caused by suspected or confirmed methicillin-resistant Staphylococcus aureus in elderly US patients.
M. McCollum, S. Sorensen, Larry Z. Liu
2007Clinical Therapeutics38 citations
Semantic Scholar
A Taxonomy and Economic Consequences of Nursing Home Falls
S. Sorensen, G. de Lissovoy, Dan Kunaprayoon, B. Resnick +2 more
2006Drugs & Aging37 citations
Semantic Scholar
Comparison of the metabolic and economic consequences of long-term treatment of schizophrenia using ziprasidone, olanzapine, quetiapine and risperidone in Canada: a cost-effectiveness analysis.
R. McIntyre, L. Cragin, S. Sorensen, H. Naci +2 more
2010Journal of Evaluation In Clinical Practice34 citations
Semantic Scholar
Pharmacoeconomics Impact of Linezolid on Economic Outcomes and Determinants of Cost in a Clinical Trial Evaluating Patients with MRSA Complicated Skin and Soft-Tissue Infections
P. Mckinnon, S. Sorensen, Larry Z. Liu, K. Itani
2006The Annals of Pharmacotherapy33 citations
Semantic Scholar
QL4 PATIENT-RATED UTILITIES IN POSTMENOPAUSAL EARLY BREAST CANCER (EBC):A CROSS-COUNTRY COMPARISON
S. Sorensen, Ruth E. Brown, Á. Benedict, E. Flood +1 more
200431 citations Open access
Semantic Scholar
Cost-effectiveness of new oral anticoagulants in the prevention of stroke in patients with atrial fibrillation.
A. Kansal, Ying Zheng, T. Pokora, S. Sorensen
2013Baillière's Best Practice & Research: Clinical Haematology30 citations
Semantic Scholar
Modeling Treatment Sequences in Pharmacoeconomic Models
Ying Zheng, F. Pan, S. Sorensen
2016PharmacoEconomics (Auckland)29 citations
Semantic Scholar
Cost-effectiveness of linezolid versus vancomycin for hospitalised patients with complicated skin and soft-tissue infections in Germany
D. Schürmann, S. Sorensen, E. De Cock, S. Duttagupta +1 more
2009European Journal of Health Economics29 citations Open access
Semantic Scholar
Efficacy and cost-effectiveness of dabigatran etexilate versus warfarin in atrial fibrillation in different age subgroups.
A. Clemens, S. Peng, S. Brand, M. Brueckmann +5 more
2014American Journal of Cardiology23 citations Open access
Semantic Scholar
Budgetary Impact on a U.S. Health Plan Adopting Abiraterone Acetate Plus Prednisone for the Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer
S. Sorensen, L. Ellis, Ying Wu, V. Hutchins +2 more
2013Journal of Managed Care Pharmacy21 citations Open access
Semantic Scholar
Cost-effectiveness of linezolid versus vancomycin for hospitalized patients with complicated skin and soft-tissue infections in France.
E. De Cock, S. Sorensen, F. Levrat, J. Besnier +3 more
2009Médecine et maladies infectieuses21 citations Open access
Semantic Scholar
Modeling Clinical Outcomes in Prostate Cancer: Application and Validation of the Discrete Event Simulation Approach.
F. Pan, O. Reifsnider, Ying Zheng, I. Proskorovsky +3 more
2017Value in Health19 citations Open access
Semantic Scholar
Cost-effectiveness of DTG+ABC/3TC versus EFV/TDF/FTC for first-line treatment of HIV-1 in the United States
S. Peng, A. Tafazzoli, E. Dorman, L. Rosenblatt +2 more
2014Journal of the International AIDS Society16 citations Open access
Semantic Scholar
A Comparative Analysis of Models Used to Evaluate the Cost-Effectiveness of Dabigatran Versus Warfarin for the Prevention of Stroke in Atrial Fibrillation
S. Sorensen, S. Peng, B. Monz, C. Bradley-Kennedy +1 more
2013PharmacoEconomics (Auckland)15 citations Open access
Semantic Scholar
Cost-Effectiveness of Lisocabtagene Maraleucel Versus Axicabtagene Ciloleucel and Tisagenlecleucel in the Third-Line or Later Treatment Setting for Relapsed or Refractory Large B-cell Lymphoma in the United States
C. Parker, Fei Liu, K. Deger, C. Franco-Villalobos +3 more
2023Advances in Therapy14 citations Open access
Semantic Scholar
Cost-effectiveness of DTG + ABC/3TC versus EFV/TDF/FTC for first-line treatment of HIV-1 in the United States
S. Peng, A. Tafazzoli, E. Dorman, L. Rosenblatt +2 more
2015Journal of Medical Economics13 citations Open access
Semantic Scholar
Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
S. Sorensen, K. Frick, A. Wade, R. Simko +1 more
2009Clinical Therapeutics13 citations
Semantic Scholar
The Cost-Effectiveness of Ibrutinib in Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia
S. Sorensen, S. Peng, E. Dorman, S. Côté +3 more
201611 citations
Semantic Scholar
Indirect Treatment Comparisons of Ibrutinib Versus Physician's Choice and Idelalisib Plus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia.
S. Sorensen, M. Wildgust, N. Sengupta, C. Trambitas +4 more
2017Clinical Therapeutics10 citations
Semantic Scholar
Inclusion of compliance and persistence in economic models: past, present and future.
Ananth Kadambi, R. Leipold, A. Kansal, S. Sorensen +1 more
2012Applied Health Economics and Health Policy10 citations
Semantic Scholar
Economic Evaluation of Nivolumab Plus Ipilimumab Combination as First-Line Treatment for Patients with Advanced Melanoma in Canada
P. Quon, Xiao Ying, S. Sorensen, A. Monfared
2019PharmacoEconomics - Open8 citations Open access
Semantic Scholar
Economic evaluation of azoles as primary prophylaxis for the prevention of invasive fungal infections in Spanish patients undergoing allogeneic haematopoietic stem cell transplant
C. Solano, M. Slavin, A. Shaul, D. Marks +13 more
2017Mycoses (Berlin)7 citations Open access
Semantic Scholar
Inclusion of Compliance and Persistence in Economic Models
Ananth Kadambi, R. Leipold, A. Kansal, S. Sorensen +1 more
2012Applied Health Economics and Health Policy7 citations
Semantic Scholar
Cost-effectiveness of entecavir versus adefovir for the treatment of chronic hepatitis B in patients with decompensated cirrhosis from a third-party US payer perspective
N. Tsai, L. Jeffers, L. Cragin, S. Sorensen +5 more
2012ClinicoEconomics and Outcomes Research7 citations Open access
Semantic Scholar
PIN2 COST-EFFECTIVENESS OF LINEZOLID VERSUS VANCOMYCIN IN SUSPECTED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS IN NOSOCOMIAL PNEUMONIA IN GERMANY
T. Grünewald, E. De Cock, S. Sorensen, T. Baker +3 more
20047 citations Open access
Semantic Scholar
Modeling hard clinical end-point data in economic analyses
A. Kansal, Ying Zheng, R. Palencia, A. Ruffolo +2 more
2013Journal of Medical Economics6 citations
Semantic Scholar
Decision analysis modelling of costs and outcomes following cefepime monotherapy in Canada.
M. Halpern, Ruth E. Brown, M. Drolet, S. Sorensen +1 more
1997The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses4 citations Open access
Semantic Scholar
Cost-Effectiveness of Lisocabtagene Maraleucel (liso-cel) Versus Axicabtagene Ciloleucel (axi-cel) for Treatment of Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL)
C. Parker, Fei Liu, K. Deger, C. Franco-Villalobos +4 more
2021Blood3 citations
Semantic Scholar
Simulation Model of Ibrutinib in Treatment of Relapsed or Refractory Mantle Cell Lymphoma (MCL).
S. Peng, S. Sorensen, F. Pan, E. Dorman +4 more
2014Value in Health3 citations Open access
Semantic Scholar
Simulation Model of Ibrutinib for Chronic Lymphocytic Leukemia (CLL) With Prior Treatment.
F. Pan, S. Peng, S. Sorensen, E. Dorman +3 more
2014Value in Health3 citations Open access
Semantic Scholar
PIN3 LINEZOLID FOR THE TREATMENT OF SKIN AND SOFT-TISSUE MRSA INFECTIONS—A COST-EFFECTIVE ALTERNATIVE TO VANCOMYCIN: EVIDENCE FROM A MULTINATIONAL CLINICAL TRIAL
S. Sorensen, C. Hollenbeak, T. Baker, A. Resch +1 more
20043 citations Open access
Semantic Scholar
Comment on: “Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal”
O. Reifsnider, F. Hall, S. Sorensen, I. Proskorovsky +2 more
2017PharmacoEconomics (Auckland)2 citations
Semantic Scholar
Modeling Treatments and Outcomes in Metastatic Castration-Resistant Prostate Cancer: A Case Study of Discrete Event Simulation and the Challenges for A UK Nice Evaluation
S. Sorensen, F. Hall, O. Reifsniderf, L. Dearden +1 more
20162 citations Open access
Semantic Scholar
How inducing covariation in simulated HDL-C, triglyceride, and total cholesterol data affects Framingham risk equation results.
K. Frick, S. Sorensen, C. Hollenbeak
2008Value in Health2 citations Open access
Semantic Scholar
Medical resource utilization (MRU) of abiraterone acetate plus prednisone (AAP) added to androgen deprivation therapy (ADT) in metastatic castration-naive prostate cancer: Results from LATITUDE.
Tracy Li, C. Franco-Villalobos, I. Proskorovsky, S. Sorensen +3 more
20181 citations
Semantic Scholar
Medical resource utilization of abiraterone acetate plus prednisone added to androgen deprivation therapy in metastatic castration‐naive prostate cancer: Results from LATITUDE
Tracy Li, C. Franco-Villalobos, I. Proskorovsky, S. Sorensen +3 more
2018Cancer1 citations
Semantic Scholar
Abstract 14964: Cost-Effectiveness of Dabigatran Etexilate versus Rivaroxaban for Stroke and Systemic Embolism Risk Reduction in Atrial Fibrillation: A US Third Party Payer Perspective
S. Sorensen, S. Peng, David C. Walker, S. Sander +1 more
20121 citations
Semantic Scholar
Cost-Effectiveness of Linezolid versus Vancomycin in the Treatment of Complicated Skin and Soft Tissue Infection due to Proven or Suspected MRSA
S. Sorensen
20041 citations
Semantic Scholar
PCN17: AN ANALYSIS OF RESOURCE USE IN THE TREATMENT OF ADVANCED COLORECTAL CANCER IN THE UK
S. Sorensen, R. Brown, E. De Cock, A. Bearne
20011 citations Open access
Semantic Scholar
PMDM3: PROJECTING ECONOMIC RESULTS OF A EUROPEAN TRIAL TO THE UNITED STATES: ISSUES AND METHODS
S. Sorensen, G. de Lissovoy, S. Mathur, S. Duttagupta
20001 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Kansal×11
Invite
A. Kansal — researcher profile on SciRah
S. Peng×10
Invite
S. Peng — researcher profile on SciRah
E. Dorman×7
Invite
E. Dorman — researcher profile on SciRah
I. Proskorovsky×6
Invite
I. Proskorovsky — researcher profile on SciRah

×5

Invite

F. Pan — researcher profile on SciRah

Invite

E. De Cock — researcher profile on SciRah

Invite

L. Cragin — researcher profile on SciRah

Invite

A. Resch — researcher profile on SciRah

S. Duttagupta×4

Invite

S. Duttagupta — researcher profile on SciRah

C. Franco-Villalobos×4

Invite

C. Franco-Villalobos — researcher profile on SciRah

C. Bradley-Kennedy×3

Invite

C. Bradley-Kennedy — researcher profile on SciRah

Invite

J. Plumb — researcher profile on SciRah